Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

James Hok-Fung Chan

DPhil student

Tumour hypoxia represents a major obstacle for cancer therapies. In order to improve the effectiveness of cancer treatments, a better understanding of cellular responses in tumour hypoxia is urgently needed.

My current research studies the roles of the tumour suppressor ASPP2 in tumour hypoxia. Using a multi-omics approach, including ChIP- and RNA-sequencing, together with bioinformatics from patient samples, we seek to understand how ASPP2 regulates the major signalling pathways in hypoxia and how the dysfunction of ASPP2 may impact the adaptation of tumour cells to hypoxia.